Ingersoll Rand Inc. IR has revved up its growth engine by finalizing a deal to acquire ILC Dover from New Mountain Capital, LLC for a hefty $2.325 billion in upfront cash. This strategic move not only adds a substantial value to Ingersoll Rand’s portfolio but also includes an earnout based on specific operational efficiency targets set for the current year.
ILC Dover specializes in crafting cutting-edge solutions for the biopharmaceutical, pharmaceutical, aerospace, and medical device sectors. With a workforce exceeding 2,000 employees, the company boasts a strong clientele base with 11 engineering and production facilities scattered across North America, Asia, and Europe.
Strategic Synergy
This acquisition aligns seamlessly with Ingersoll Rand’s overarching strategy to fortify its operations and broaden its market footprint. The addition of ILC Dover’s disposable solutions for biopharma and pharma manufacturing processes perfectly complements Ingersoll Rand’s proficiency in liquid handling technologies and positive displacement pumps. By establishing a dedicated life sciences platform, Ingersoll Rand anticipates a revenue boost of $700 million, significantly propelling its growth trajectory in the burgeoning life sciences sector.
Following the acquisition, ILC Dover will be integrated into IR’s Precision & Science Technologies segment and will be spearheaded by ILC’s President and CEO, Corey Walker. This move also opens the floodgates for Ingersoll Rand to tap into approximately 1,000 customers within the expansive life science and healthcare markets.
Market Performance and Projections
With a market capitalization of around $38.1 billion, Ingersoll Rand currently holds a Zacks Rank #2 (Buy). The company stands to benefit from a robust demand environment, a diverse product lineup, and a track record of fostering innovation. Bolstering its position is the robust cash flow it generates, which fuels its strategic capital allocation initiatives.
Image Source: Zacks Investment Research
Over the past three months, Ingersoll Rand’s shares have soared by 21.4%, outpacing the industry’s 10.4% growth rate. The Zacks Consensus Estimate for its 2024 earnings stands at $3.20, reflecting a 3.2% increase from figures reported 60 days ago.
Exploring Potential Opportunities
In addition to Ingersoll Rand, there are three other promising stocks in the same sector worth exploring: Applied Industrial Technologies (AIT), Parker-Hannifin Corporation (PH), and Luxfer Holdings plc (LXFR), all boasting a Zacks Rank #2. For a comprehensive list of today’s top-performing Zacks #1 Rank (Strong Buy) stocks, click here.
Applied Industrial has been consistent in delivering a 10.4% average earnings surprise over the past four quarters. Recent data also suggests a 1.7% rise in the Zacks Consensus Estimate for AIT’s 2024 earnings compared to the previous 60-day estimate.
Parker-Hannifin has maintained an average earnings surprise of 14.4% over the past four quarters, with a 4.2% increase in the Zacks Consensus Estimate for its 2024 earnings over the last 60 days.
Luxfer Holdings has been a standout performer with an astounding 82.7% average earnings surprise over the past four quarters. Market estimates for LXFR’s 2024 earnings have surged by an impressive 111.4% in the last 60 days.
Opportunities Knocking
Stay ahead of the curve: An exclusive selection panel has pinpointed 7 elite stocks from a roster of 220 Zacks Rank #1 Strong Buys as the ones “Most Likely for Early Price Pops.”
Evidence since 1988 illustrates that this list has outperformed the market by over 2X, boasting an annual average gain of +24.2%. Waste no time in exploring these carefully chosen selections.
Parker-Hannifin Corporation (PH) : Free Stock Analysis Report
Applied Industrial Technologies, Inc. (AIT) : Free Stock Analysis Report
Ingersoll Rand Inc. (IR) : Free Stock Analysis Report
Luxfer Holdings PLC (LXFR) : Free Stock Analysis Report
For the full story, visit Zacks.com here.
Opinions expressed here are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
